Novel Rationally Designed Lipopeptides Derived from Bacitracin: Combating Multidrug Resistance and Evading Bacitracin Resistance via Potentiated Cell Wall and Membrane Inhibitions
Sijie Cheng(Advanced Research Institute), Dongliang Guan(Chinese Academy of Sciences), Yanping Zhu(Yantai University), Jinyong Zhang(Qingdao Agricultural University), Fang Li(Chinese Academy of Sciences), Zhifu Chen(Army Medical University), Jingwen Liao(Army Medical University)
Cited by 4
Related Papers
Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug‐Resistant Bacteria
|Angewandte Chemie International Edition|2019|92
Selective N-glycan editing on living cell surfaces to probe glycoconjugate function
|Nature Chemical Biology|2020|64
Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant <i>Staphylococcus aureus</i> and Vancomycin-Resistant <i>Enterococci</i>
|Journal of Medicinal Chemistry|2017|59
Potentiation of Vancomycin: Creating Cooperative Membrane Lysis through a “Derivatization-for-Sensitization” Approach
|Journal of the American Chemical Society|2022|32
Design and synthesis of novel dual-cyclic RGD peptides for αvβ3 integrin targeting
|Bioorganic & Medicinal Chemistry Letters|2019|22